Addus HomeCare Q3 Revenue Hits $387.7M, EPS Beats

Addus HomeCare Corporation (NASDAQ: ADUS) reported third quarter 2026 net service revenues of $387.7 million, a 7.0% increase from $362.3 million a year earlier, the Frisco, Texas-based home care provider announced on November 3, 2026. Net income reached $28.6 million, or $1.54 per diluted share, while adjusted net income per diluted share rose 17.3% year-over-year to $1.83. Adjusted EBITDA climbed 13.5% to $51.2 million, and cash flow from operations totaled $40.9 million for the quarter.

Context — why the home care print matters now

Addus operates in a segment where demand is tied to aging populations and payer mix rather than discretionary consumer spending, so a 7.0% top-line expansion with margin growth signals operational use rather than volume rebounding from a weak base. The company said personal care services accounted for 77.6% of third quarter revenues and delivered a 6.9% organic revenue increase over the prior-year quarter.

The comparison base matters. Third quarter 2025 included a benefit from an implicit price concession in hospice that flattered that period. Excluding that benefit, the company said hospice organic revenue grew 8.8% in the most recent quarter, a cleaner read on underlying momentum than the headline hospice figure alone.

Management framed the quarter around profitable growth and cost discipline. Chief Executive Officer Dirk Allison said the results reflect "another strong quarter of profitable growth and operational execution across our service lines," attributing margin expansion to disciplined cost controls and operating use. The company's gross profit margin was 32.1%, essentially flat against 32.2% a year earlier, which means the EBITDA expansion came from below the gross line.

The strategic catalyst is the pending acquisition of the personal care division of AccentCare for approximately $275.0 million, announced September 14, 2026. Addus said the deal covers AccentCare's personal care operations outside New York and is expected to close after regulatory approvals and customary closing conditions.

Data — what the numbers show

Revenue, earnings, and cash generation all moved in the same direction for the quarter. Net income rose to $28.6 million from $22.8 million, and diluted earnings per share increased to $1.54 from $1.24.

Adjusted figures strip out acquisition expenses, stock-based compensation, and restructuring costs. For the third quarter of 2026, adjusted net income per diluted share of $1.83 excluded $0.16 in acquisition expenses, $0.12 in stock-based compensation, and $0.01 in restructuring and other non-recurring costs. Adjusted net income was $33.9 million versus $28.7 million in the prior-year period.

Metric	Q3 2026	Q3 2025	Change
Net service revenues	$387.7M	$362.3M	+7.0%
Net income	$28.6M	$22.8M	+25.2%
Diluted EPS	$1.54	$1.24	+24.2%
Adjusted diluted EPS	$1.83	$1.56	+17.3%
Adjusted EBITDA	$51.2M	$45.1M	+13.5%

Through the first nine months of 2026, net service revenues rose 7.6% to $1.129 billion from $1.049 billion, net income reached $81.3 million versus $66.1 million, and adjusted EBITDA increased 11.8% to $144.9 million. Adjusted diluted EPS for the nine-month period was $5.19 against $4.48 a year earlier.

Balance sheet metrics support the growth story. As of September 30, 2026, Addus held $98.5 million in cash against $24.3 million in bank debt, with $650.0 million of capacity and $617.8 million of availability under its revolving credit facility.

Analysis — what it means for healthcare services

Addus's low use gives it room to absorb a $275.0 million purchase without straining the balance sheet, which management explicitly framed as a competitive advantage. Allison said the company maintains "significant liquidity and financial capacity to fund strategic growth investments, which includes the pending AccentCare personal care division acquisition."

The AccentCare personal care division would add roughly $280 million in annualized revenue, which Addus said represents a nearly 19% expansion of its total revenue base. That scale matters in home care because density drives caregiver utilization and scheduling efficiency, and the deal would extend the company's footprint across Texas, Illinois, California, and Arizona.

The counter-argument is integration risk. Personal care acquisitions bring large caregiver workforces, state-by-state rate structures, and payer contracts that can take quarters to normalize. Addus already flagged acquisition expenses of $0.16 per diluted share in the quarter, and the AccentCare close depends on regulatory approvals the company did not put a date on.

Sector exposure runs through home health and hospice peers, plus managed care organizations that contract for in-home care. Addus said offering all three levels of care strengthens its ability to collaborate clinically with managed care plans and value-based partners, which positions it as a counterparty rather than a vendor in those negotiations.

Positioning is straightforward: the print supports the long case for home care operators with clean balance sheets, while the pending deal keeps event-driven interest in ADUS shares. The company did not disclose specific terms beyond the approximate purchase price.

Outlook — what to watch next

Addus will host a conference call on Wednesday, November 4, 2026, at 9:00 a.m. Eastern Time, with Allison and Executive Vice President and Chief Financial Officer Brian Poff participating. A telephonic replay runs through midnight on November 11, 2026.

The primary catalyst is the AccentCare personal care division acquisition. The company said the deal is expected to close following completion of regulatory approvals and subject to customary closing conditions, but did not provide a target date. Any update on timing or adjusted purchase price is the next hard data point.

Operationally, watch personal care organic growth and hospice average daily census, which rose 4.3% organically year-over-year in the quarter. Rate adjustments in Illinois, Texas, and New Mexico have supported growth historically, and any change to state reimbursement schedules would flow directly into the personal care segment that carries most of the revenue base.

Frequently Asked Questions

What does the Addus HomeCare Q3 2026 report mean for retail investors?

It shows a home care operator growing revenue 7.0% to $387.7 million while expanding adjusted EBITDA 13.5% to $51.2 million, with $40.9 million of quarterly operating cash flow. The company carries $24.3 million in bank debt against $98.5 million in cash. For retail investors, the key signal is that margin expansion came alongside volume growth rather than from cost cuts alone, though the pending $275.0 million acquisition adds execution risk.

Why did Addus adjusted EPS rise more than net income per share?

Adjusted diluted EPS of $1.83 excluded $0.16 in acquisition expenses, $0.12 in stock-based compensation, and $0.01 in restructuring costs, totaling $0.29 per share in excluded items. Reported diluted EPS of $1.54 includes those charges. Because acquisition costs tied to the AccentCare deal are non-recurring, the adjusted figure is the cleaner comparison against the prior-year $1.56, a 17.3% increase.

What happens next for the AccentCare personal care acquisition?

Addus announced a definitive agreement on September 14, 2026, to acquire AccentCare's personal care division outside New York for approximately $275.0 million. The company said the deal is expected to close following regulatory approvals and customary closing conditions, and did not disclose a target date. The transaction would add roughly $280 million in annualized revenue, expanding Addus's total revenue base by nearly 19%.

Bottom Line

Addus delivered 7.0% revenue growth with 13.5% adjusted EBITDA expansion, and the pending AccentCare deal would add nearly 19% to its revenue base.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.